Amicus Therapeutics Announces First Quarter 2014 Financial Results and Corporate Updates

[GlobeNewswire] – Positive 12- and 24-Month Data From First Phase 3 Fabry Monotherapy Study (Study 011) — Results from Second Phase 3 Fabry Monotherapy Study (Study 012) Expected 3Q14 more

View todays social media effects on FOLD

View the latest stocks trending across Twitter. Click to view dashboard

See who Amicus is hiring next, click here to view